Cochrane Abstracts
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility: Cochrane systematic review
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Insulin-sensitising Drugs (metformin, Rosiglitazone, Pioglitazone, D-chiro-inositol) for Women With Polycystic Ovary Syndrome, Oligo Amenorrhoea and Subfertility: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433089/all/Insulin_sensitising_drugs__metformin_rosiglitazone_pioglitazone_D_chiro_inositol__for_women_with_polycystic_ovary_syndrome_oligo_amenorrhoea_and_subfertility:_Cochrane_systematic_review. Accessed 17 January 2021.
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433089/all/Insulin_sensitising_drugs__metformin_rosiglitazone_pioglitazone_D_chiro_inositol__for_women_with_polycystic_ovary_syndrome_oligo_amenorrhoea_and_subfertility:_Cochrane_systematic_review. Accessed January 17, 2021.
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility: Cochrane systematic review. In Cochrane Abstracts Retrieved January 17, 2021, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/433089/all/Insulin_sensitising_drugs__metformin_rosiglitazone_pioglitazone_D_chiro_inositol__for_women_with_polycystic_ovary_syndrome_oligo_amenorrhoea_and_subfertility:_Cochrane_systematic_review
Insulin-sensitising Drugs (metformin, Rosiglitazone, Pioglitazone, D-chiro-inositol) for Women With Polycystic Ovary Syndrome, Oligo Amenorrhoea and Subfertility: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433089/all/Insulin_sensitising_drugs__metformin_rosiglitazone_pioglitazone_D_chiro_inositol__for_women_with_polycystic_ovary_syndrome_oligo_amenorrhoea_and_subfertility:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility: Cochrane systematic review
ID - 433089
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433089/all/Insulin_sensitising_drugs__metformin_rosiglitazone_pioglitazone_D_chiro_inositol__for_women_with_polycystic_ovary_syndrome_oligo_amenorrhoea_and_subfertility:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
